For brain surgeons, the shift is the sticking point. When a surgeon opens the cranium to remove a tumor, the brain moves as much as 1 cm, making much of the pre-operative mapping of the tumor essentially useless. While the bulk of a lesion can be identified by its density, the tendrils blend into the surrounding tissue – and taking excess margins means more brain damage. Designs for Vision Inc.’s bright idea, a headlamp that illuminates a fluorescing tumor with a laser light, makes brain surgery quicker, safer and more accurate. Read More
PARIS – Bone 3D SAS has signed a partnership with Stratasys Ltd. to put 3D printing technology directly into the hands of all 3,000 French hospitals and their front-line medical professionals. This new service, called Hospifactory, makes it possible to leverage additive manufacturing to produce medical equipment and devices directly on site at the hospital. Read More
Peking Jabrehoo Med Tech Co. Ltd.’s genetic testing kit won marketing approval from China’s NMPA. It is the first preimplantation genetic testing for aneuploidy (PGT-A) that uses the reversible termination sequencing method in China, according to the company. Read More
Artificial intelligence (AI) is quite the buzzword for med tech and regulators alike, but that doesn’t mean rules for AI are just over the horizon. Pat Baird, director of global software standards at Koninklijke Philips NV, said during a recent webinar that problems such as long-standing definitional issues virtually guarantee that regulatory agencies will struggle to enact regulations, a predicament that leaves software developers with the kind of uncertainty that investors in the life science industries abhor. Read More
A research report by global investment bank Jefferies has found increased investor optimism in the health care market amid COVID-19, with respondents expecting stocks to rise throughout 2022. The Jefferies Healthcare Temperature Check summarizes the views of 500 leaders across the health care sector. Sixty percent of respondents said they believed the MSCI World Health Care Index would be higher by the end of 2022 than at present. Read More
Reps. Diana DeGette (D-Colo.) and Fred Upton (R-Mich.) have reintroduced Cures 2.0, legislation they said will increase access to live-saving cures and treatments for a variety of diseases such as Alzheimer’s disease.
New hires and promotions in the med-tech industry, including: Angle, DNA Script, Heartflow, Indegene, Rebus Biosystems, Saluda Medical, Selux Diagnostics, Talis Biomedical, Valam. Read More
Med-tech firms raising money in public or private financings, including: Certara, Geneoscopy, Kedalion, Marani Health, Self Decode, Synthace. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiologs, Genetron, Precision Diabetes. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anatomics, D&P Bioinnovations, Hemex, Hudson Medical, Illumigyn, Lambell Ghana, Nextgen Healthcare, Peramare Pharmaceuticals, Merck, Milliporesigma, Resonetics, Sanbio, Validic, Vida Diagnostics. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advantis Medical, GE Healthcare, Royal Philips. Read More
